Helping our patient communities and advancing knowledge in our therapy areas is part of our corporate responsibility.
It is our mission to discover, develop, and deliver innovative therapies that improve patients' quality of life.
We work with government authorities to ensure patients have access to care while also funding medical research.
We also aim to make sure that nothing holds you back from getting the therapies you need.
Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise.
A clinical trial is a research study that is done to find out if medical treatments can improve people’s health.
Every day at CSL Behring, we work as if someone’s life depends on it, because it does.
CSL Behring biotherapies are manufactured in state-of-the-art facilities under stringent, controlled conditions.
Help us deliver on our promise to save lives and protect the health of people.
Make your well-being a priority. It's important and so are you.
“Hope Lives Here” connects Jamaican teens living with blood disorder.
Healthcare panel will explore how tech can build a bridge and involve patients every step of the way.
Mentors can help guide young sickle cell disease patients.
Learn how young adult sickle cell disease patients can move out of pediatric care and take control of their health.
On our new podcast episode, a Sickle Cell Disease patient discusses the challenges of her transition to adulthood.
Our animation explains the rare blood disorder and what CSL Behring is doing to help.
Advances in treating rare blood disorder grab media spotlight.
Challenges and hope found on visit to Jamaica sickle cell unit.
Popular search terms:
Americas
Asia Pacific
Europe
